Prediction of disease-free survival for precision medicine using cooperative learning on multi-omic data

Author:

Hahn Georg1,Prokopenko Dmitry2,Hecker Julian3,Lutz Sharon M1,Mullin Kristina2,Sejour Leinal4,Hide Winston4,Vlachos Ioannis4,DeSantis Stacia5,Tanzi Rudolph E2,Lange Christoph1

Affiliation:

1. Department of Biostatistics, Harvard T.H. Chan School of Public Health , 677 Huntington Ave, 02115, Boston, MA , USA

2. Department of Neurology, Genetics and Aging Research Unit, McCance Center for Brain Health, Massachusetts General Hospital , 55 Fruit Street, 02114, Boston, MA , USA

3. Channing Divsion of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School , 75 Francis Street, 02115, Boston, MA , USA

4. Department of Pathology, Beth Israel Deaconess Medical Center , 330 Brookline Avenue, 02215, Boston, MA , USA

5. Houston Campus, The University of Texas Health Science Center , 1200 Pressler Street, 77030, Houston, TX , USA

Abstract

Abstract In precision medicine, both predicting the disease susceptibility of an individual and forecasting its disease-free survival are areas of key research. Besides the classical epidemiological predictor variables, data from multiple (omic) platforms are increasingly available. To integrate this wealth of information, we propose new methodology to combine both cooperative learning, a recent approach to leverage the predictive power of several datasets, and polygenic hazard score models. Polygenic hazard score models provide a practitioner with a more differentiated view of the predicted disease-free survival than the one given by merely a point estimate, for instance computed with a polygenic risk score. Our aim is to leverage the advantages of cooperative learning for the computation of polygenic hazard score models via Cox’s proportional hazard model, thereby improving the prediction of the disease-free survival. In our experimental study, we apply our methodology to forecast the disease-free survival for Alzheimer’s disease (AD) using three layers of data. One layer contains epidemiological variables such as sex, APOE (apolipoprotein E, a genetic risk factor for AD) status and 10 leading principal components. Another layer contains selected genomic loci, and the last layer contains methylation data for selected CpG sites. We demonstrate that the survival curves computed via cooperative learning yield an AUC of around $0.7$, above the state-of-the-art performance of its competitors. Importantly, the proposed methodology returns (1) a linear score that can be easily interpreted (in contrast to machine learning approaches), and (2) a weighting of the predictive power of the involved data layers, allowing for an assessment of the importance of each omic (or other) platform. Similarly to polygenic hazard score models, our methodology also allows one to compute individual survival curves for each patient.

Funder

Cure Alzheimer's Fund

National Institutes of Health

National Science Foundation

NIH Center

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3